Journal
PLANTA MEDICA
Volume 89, Issue 3, Pages 295-307Publisher
GEORG THIEME VERLAG KG
DOI: 10.1055/a-1917-7910
Keywords
Dryopteridaceae; Dryopteris crassirhizoma; acylphloroglucinol-meroterpenoid; acylphloroglucinol; Candida albicans; antifungal activity
Ask authors/readers for more resources
Novel meroterpenoids with unique structures were isolated from D. crassirhizoma, showing promising antifungal and antibacterial activities, indicating their potential as drug candidates.
Ten novel meroterpenoids, dryoptins/11 ''-epi-dryoptins A similar to E (1 similar to 10 ) with an unprecedented skeleton consisting of dimeric or trimeric acylphloroglucinols and dehydrotheonelline, two undescribed acylphloroglucinol-nerolidol meroterpenoids (11 similar to 12 ), and ten known acylphloroglucinol derivatives (13 similar to 22 ), were isolated from D. crassirhizoma. The novel structures including absolute configurations were established by comprehensive spectroscopic analyses and quantum chemical electronic circular dichroism (ECD) calculations. A biosynthetic pathway of 1 similar to 10 was assumed. The trimeric acylphloroglucinol meroterpenoids 7 / 8 showed significant antifungal activity against standard Candida albicans with a MIC50 value of 1.61 mu g/mL [fluconazole (FLC): 3.41 mu g/mL], and when combined with FLC, the principal components 20 and 21 exhibited strong antifungal activities against FLC-resistant C. albicans with MIC (50) values of 8.39 and 7.16 mu g/mL (FLC: > 100 mu g/mL), respectively. Moreover, compounds 2, 5 / 6, 18, 19 , and 21 exhibited inhibitory effects against several pathogenic fungi and bacteria, with MIC50 values of 6.25 similar to 50 mu g/mL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available